Please enable JavaScript to continue using this application.

Compare $GNLX vs $XGN | Chartloom

Compare

$GNLX vs $XGN

Genelux Corp · Exagen Inc

GNLX

Genelux Corp

XGN

Exagen Inc

Compare $GNLX vs $XGN

Comparing Genelux Corp and Exagen Inc

GNLXGenelux Corp

XGNExagen Inc

GNLXGenelux Corp

Market cap

$115M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-43.7%

52W performance

-46.1%

FCF yield

-25.0%

XGNExagen Inc

Market cap

$203M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

2.63x

Rev growth (TTM)

20.8%

YTD performance

39.4%

52W performance

-23.3%

FCF yield

-3.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

GNLX

XGN

Detailed metrics comparison

GNLX

Genelux Corp

XGN

Exagen Inc

Market Cap

GNLX$115M

XGN$203M

Enterprise Value

GNLX$106M

XGN$204M

Price

GNLX$2.56

XGN$8.42

P/E Ratio

GNLXN/A

XGNN/A

P/S Ratio

GNLX14,348.80x

XGN2.86x

EV/Sales

GNLX13,200.80x

XGN2.87x

EV/EBITDA

GNLX0.00x

XGN0.00x

P/B Ratio

GNLX7.19x

XGN16.60x

P/FCF Ratio

GNLXN/A

XGNN/A

EV/FCF

GNLX-3.68x

XGN-26.94x

PEG Ratio

GNLXN/A

XGNN/A

Forward P/E (NTM)

GNLXN/A

XGNN/A

Forward P/S (NTM)

GNLXN/A

XGN2.63x

Revenue (TTM)

GNLX$8K

XGN$71M

Revenue Growth (YoY)

GNLXN/A

XGN20.8%

Forward Rev Growth

GNLX551.6%

XGN10.1%

Gross Margin (TTM)

GNLX0.0%

XGN58.6%

Operating Margin (TTM)

GNLX0.0%

XGN0.0%

EBITDA Margin (TTM)

GNLX-453500.0%

XGN-15.1%

Net Margin (TTM)

GNLX-444950.0%

XGN-26.6%

FCF Margin (TTM)

GNLX-358537.5%

XGN-10.7%

Net Income (TTM)

GNLX$-36M

XGN$-19M

FCF (TTM)

GNLX$-29M

XGN$-8M

EPS (TTM)

GNLX-$0.79

XGN-$0.78

ROE (TTM)

GNLX-20585.0%

XGN-12162.0%

ROA (TTM)

GNLX-13879.0%

XGN-3368.0%

ROIC (TTM)

GNLX-20585.0%

XGN-4566.0%

Cash

GNLX$9M

XGN$25M

Debt

GNLX$0

XGN$26M

Net Cash/Debt

GNLX$9M

XGN$-959K

Current Ratio (TTM)

GNLX2.39x

XGN3.18x

Quick Ratio (TTM)

GNLX2.33x

XGN2.75x

Debt/Equity (TTM)

GNLX0.00x

XGN2.09x

Debt/Assets (TTM)

GNLX0.0%

XGN0.0%

Interest Coverage (TTM)

GNLXN/A

XGNN/A

Net Debt/EBITDA (TTM)

GNLX0.00x

XGN0.00x

Beta

GNLX0.56

XGN2.28

52W Performance

GNLX-46.1%

XGN-23.3%

YTD Performance

GNLX-43.7%

XGN39.4%

% from 52W High

GNLX-70.0%

XGN-31.2%

% from 52W Low

GNLX11.8%

XGN225.1%

Asset Turnover (TTM)

GNLX0.00x

XGN1.27x

FCF Yield (TTM)

GNLX-25.0%

XGN-3.7%

Earnings Yield (TTM)

GNLX-31.0%

XGN-9.3%

Dividend Yield (TTM)

GNLXN/A

XGNN/A

Rule of 40

GNLX-358,537.5

XGN10.2

EV/GP/RG

GNLXN/A

XGN0.55

Ticker research

View GNLX research View XGN research

Metric	GNLX Genelux Corp	XGN Exagen Inc
Market & Valuation
Market Cap	$115M	$203M
Enterprise Value	$106M	$204M
Price	$2.56	$8.42
P/E Ratio	N/A	N/A
P/S Ratio	14,348.80x	2.86x
EV/Sales	13,200.80x	2.87x
EV/EBITDA	0.00x	0.00x
P/B Ratio	7.19x	16.60x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.68x	-26.94x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	2.63x
Revenue & Growth
Revenue (TTM)	$8K	$71M
Revenue Growth (YoY)	N/A	20.8%
Forward Rev Growth	551.6%	10.1%
Profitability
Gross Margin (TTM)	0.0%	58.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-453500.0%	-15.1%
Net Margin (TTM)	-444950.0%	-26.6%
FCF Margin (TTM)	-358537.5%	-10.7%
Net Income (TTM)	$-36M	$-19M
FCF (TTM)	$-29M	$-8M
EPS (TTM)	-$0.79	-$0.78
ROE (TTM)	-20585.0%	-12162.0%
ROA (TTM)	-13879.0%	-3368.0%
ROIC (TTM)	-20585.0%	-4566.0%
Financial Health
Cash	$9M	$25M
Debt	$0	$26M
Net Cash/Debt	$9M	$-959K
Current Ratio (TTM)	2.39x	3.18x
Quick Ratio (TTM)	2.33x	2.75x
Debt/Equity (TTM)	0.00x	2.09x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.56	2.28
52W Performance	-46.1%	-23.3%
YTD Performance	-43.7%	39.4%
% from 52W High	-70.0%	-31.2%
% from 52W Low	11.8%	225.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	1.27x
FCF Yield (TTM)	-25.0%	-3.7%
Earnings Yield (TTM)	-31.0%	-9.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-358,537.5	10.2
EV/GP/RG	N/A	0.55
Ticker research	View GNLX research	View XGN research

Valuation

P/S Ratio

XGN

2.86x

GNLX

14,348.80x

EV/FCF

XGN

-26.94x

GNLX

-3.68x

Growth & revenue

Revenue Growth TTM

XGN

20.8%

Forward Revenue Growth

GNLX

551.6%

XGN

10.1%

Profitability & performance

Gross Margin

XGN

58.6%

GNLX

0.0%

ROE

XGN

-12162.0%

GNLX

-20585.0%

FCF Yield %

XGN

-3.7%

GNLX

-25.0%

52-Week Performance

XGN

-23.3%

GNLX

-46.1%

Detailed metrics comparison

GNLX

Genelux Corp

XGN

Exagen Inc

Market Cap

GNLX$115M

XGN$203M

Enterprise Value

GNLX$106M

XGN$204M

Price

GNLX$2.56

XGN$8.42

P/E Ratio

GNLXN/A

XGNN/A

P/S Ratio

GNLX14,348.80x

XGN2.86x

EV/Sales

GNLX13,200.80x

XGN2.87x

EV/EBITDA

GNLX0.00x

XGN0.00x

P/B Ratio

GNLX7.19x

XGN16.60x

P/FCF Ratio

GNLXN/A

XGNN/A

EV/FCF

GNLX-3.68x

XGN-26.94x

PEG Ratio

GNLXN/A

XGNN/A

Forward P/E (NTM)

GNLXN/A

XGNN/A

Forward P/S (NTM)

GNLXN/A

XGN2.63x

Revenue (TTM)

GNLX$8K

XGN$71M

Revenue Growth (YoY)

GNLXN/A

XGN20.8%

Forward Rev Growth

GNLX551.6%

XGN10.1%

Gross Margin (TTM)

GNLX0.0%

XGN58.6%

Operating Margin (TTM)

GNLX0.0%

XGN0.0%

EBITDA Margin (TTM)

GNLX-453500.0%

XGN-15.1%

Net Margin (TTM)

GNLX-444950.0%

XGN-26.6%

FCF Margin (TTM)

GNLX-358537.5%

XGN-10.7%

Net Income (TTM)

GNLX$-36M

XGN$-19M

FCF (TTM)

GNLX$-29M

XGN$-8M

EPS (TTM)

GNLX-$0.79

XGN-$0.78

ROE (TTM)

GNLX-20585.0%

XGN-12162.0%

ROA (TTM)

GNLX-13879.0%

XGN-3368.0%

ROIC (TTM)

GNLX-20585.0%

XGN-4566.0%

Cash

GNLX$9M

XGN$25M

Debt

GNLX$0

XGN$26M

Net Cash/Debt

GNLX$9M

XGN$-959K

Current Ratio (TTM)

GNLX2.39x

XGN3.18x

Quick Ratio (TTM)

GNLX2.33x

XGN2.75x

Debt/Equity (TTM)

GNLX0.00x

XGN2.09x

Debt/Assets (TTM)

GNLX0.0%

XGN0.0%

Interest Coverage (TTM)

GNLXN/A

XGNN/A

Net Debt/EBITDA (TTM)

GNLX0.00x

XGN0.00x

Beta

GNLX0.56

XGN2.28

52W Performance

GNLX-46.1%

XGN-23.3%

YTD Performance

GNLX-43.7%

XGN39.4%

% from 52W High

GNLX-70.0%

XGN-31.2%

% from 52W Low

GNLX11.8%

XGN225.1%

Asset Turnover (TTM)

GNLX0.00x

XGN1.27x

FCF Yield (TTM)

GNLX-25.0%

XGN-3.7%

Earnings Yield (TTM)

GNLX-31.0%

XGN-9.3%

Dividend Yield (TTM)

GNLXN/A

XGNN/A

Rule of 40

GNLX-358,537.5

XGN10.2

EV/GP/RG

GNLXN/A

XGN0.55

Ticker research

View GNLX research View XGN research

Metric	GNLX Genelux Corp	XGN Exagen Inc
Market & Valuation
Market Cap	$115M	$203M
Enterprise Value	$106M	$204M
Price	$2.56	$8.42
P/E Ratio	N/A	N/A
P/S Ratio	14,348.80x	2.86x
EV/Sales	13,200.80x	2.87x
EV/EBITDA	0.00x	0.00x
P/B Ratio	7.19x	16.60x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.68x	-26.94x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	2.63x
Revenue & Growth
Revenue (TTM)	$8K	$71M
Revenue Growth (YoY)	N/A	20.8%
Forward Rev Growth	551.6%	10.1%
Profitability
Gross Margin (TTM)	0.0%	58.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-453500.0%	-15.1%
Net Margin (TTM)	-444950.0%	-26.6%
FCF Margin (TTM)	-358537.5%	-10.7%
Net Income (TTM)	$-36M	$-19M
FCF (TTM)	$-29M	$-8M
EPS (TTM)	-$0.79	-$0.78
ROE (TTM)	-20585.0%	-12162.0%
ROA (TTM)	-13879.0%	-3368.0%
ROIC (TTM)	-20585.0%	-4566.0%
Financial Health
Cash	$9M	$25M
Debt	$0	$26M
Net Cash/Debt	$9M	$-959K
Current Ratio (TTM)	2.39x	3.18x
Quick Ratio (TTM)	2.33x	2.75x
Debt/Equity (TTM)	0.00x	2.09x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.56	2.28
52W Performance	-46.1%	-23.3%
YTD Performance	-43.7%	39.4%
% from 52W High	-70.0%	-31.2%
% from 52W Low	11.8%	225.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	1.27x
FCF Yield (TTM)	-25.0%	-3.7%
Earnings Yield (TTM)	-31.0%	-9.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-358,537.5	10.2
EV/GP/RG	N/A	0.55
Ticker research	View GNLX research	View XGN research